No Image Available

Diclofenac Diethylamine Topical Gel/Emulsion

Form: Topical Gel/Emulsion

Strength: 1%, 2%

Reference Brands: Voltaren Emulgel, Pennsaid(US)

Category: Analgesic

Diclofenac Diethylamine topical gel/emulsion is approved in both the EU and US for localized musculoskeletal pain and inflammation. In the EU, brands like Voltaren are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA approval relies on extensive clinical data, pharmacovigilance, and quality assurance. Both regions enforce strict regulations, including proper labeling, usage guidelines, and monitoring for adverse effects. For expert guidance on regulatory dossiers, compliance, and registration, visit PharmaTradz. We support seamless market access for diclofenac diethylamine gel/emulsion, ensuring adherence to European and US standards for safe, effective local anti-inflammatory therapy.

Get Enquiry Back to Listing
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.

Related Products

Dexketoprofen + Tramadol tablets

Strength: 25 mg dexketoprofen + 37.5 mg tramadol

Form: Tablets

Reference Brands: Enantyum(EU)

View Details Get Enquiry
Paracetamol + Codeine tablets

Strength: 300 mg paracetamol + 30 mg codeine; 300 mg + 60 mg

Form: Tablets

Reference Brands: Tylenol with Codeine(US)

View Details Get Enquiry
Aceclofenac + Paracetamol tablets

Strength: 100 mg Aceclofenac + 325 mg Paracetamol

Form: Tablets

Reference Brands: Generic formulations marketed under different names

View Details Get Enquiry
Tramadol + Paracetamol tablets

Strength: 37.5 mg tramadol + 325 mg paracetamol; 75 mg + 650 mg

Form: Oral Tablets

Reference Brands: Ultracet(US); Tramacet(EU)

View Details Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.